ESR1 and neoplasm: In light of recent work illuminating prognostic roles for immune-related genes in specific pathological contexts such as ER- or HER2+ breast cancer [17,30,32,33], we asked whether the prognostic performance of the immune metagenes was exclusive to the high proliferation tertile in specific tumor subtypes (Table 5).